{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:11Z","timestamp":1772165711743,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04124-5","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:13:44Z","timestamp":1743394424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quickest way to less headache days: an operational research model and its implementation for chronic migraine"],"prefix":"10.1186","volume":"25","author":[{"given":"Irene","family":"Lo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"4124_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-1","volume":"14","author":"TJ Steiner","year":"2013","unstructured":"Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain. 2013;14: 1.","journal-title":"J Headache Pain"},{"key":"4124_CR2","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","volume":"78","author":"SD Silberstein","year":"2012","unstructured":"Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337\u201345.","journal-title":"Neurology"},{"key":"4124_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-71","volume":"7","author":"T Sprenger","year":"2009","unstructured":"Sprenger T, Goadsby PJ. Migraine pathogenesis and state of pharmacological treatment options. BMC Med. 2009;7: 71.","journal-title":"BMC Med"},{"key":"4124_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017851","volume":"7","author":"D Palacios-Ce\u00f1a","year":"2017","unstructured":"Palacios-Ce\u00f1a D, Neira-Mart\u00edn B, Silva-Hern\u00e1ndez L, Mayo-Canalejo D, Florencio LL, Fernandez-de-las-Penas C, Gracia-Moreno H, Garcia-Azorin D, Cuadrado ML. Living with chronic migraine: a qualitative study on female patients\u2019 perspectives from a specialised headache clinic in Spain. BMJ Open. 2017;7: e017851.","journal-title":"BMJ Open"},{"key":"4124_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/01621459.1978.10481579","volume":"73","author":"DA Berry","year":"1978","unstructured":"Berry DA. Modified two-armed bandit strategies for certain clinical trials. J Am Stat Assoc. 1978;73:339\u201345.","journal-title":"J Am Stat Assoc"},{"key":"4124_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/sim.4780040410","volume":"4","author":"DA Berry","year":"1985","unstructured":"Berry DA, Pearson LM. Optimal designs for clinical trials with dichotomous responses. Stat Med. 1985;4:497\u2013508.","journal-title":"Stat Med"},{"key":"4124_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ejor.2015.06.077","volume":"248","author":"V Ahuja","year":"2016","unstructured":"Ahuja V, Birge JR. Response-adaptive designs for clinical trials: Simultaneous learning from multiple patients. Eur J Oper Res. 2016;248:619\u201333.","journal-title":"Eur J Oper Res"},{"key":"4124_CR8","first-page":"1225","volume":"62","author":"D Bertsimas","year":"2016","unstructured":"Bertsimas D, O\u2019Hair A, Relyea S, Silberholz J. An analytics approach to designing combination chemotherapy regimens for cancer. Manage Sci. 2016;62:1225\u2013531.","journal-title":"Manage Sci"},{"key":"4124_CR9","doi-asserted-by":"crossref","unstructured":"Steimle LN, Denton BT. Markov Decision Processes for Screening and Treatment of Chronic Diseases. In: Boucherie R, van Dijk N, eds. Markov Decision Processes in Practice. International Series in Operations Research & Management Science. Boston, MA: Springer International Publishing; 2017;248:189\u2013222.","DOI":"10.1007\/978-3-319-47766-4_6"},{"key":"4124_CR10","doi-asserted-by":"crossref","unstructured":"Schaefer AJ, Bailey MD, Shechter SM, Roberts MS. Modeling Medical Treatment Using Markov Decision Processes. In: Brandeau ML, Sainfort F, Pierskalla WP, eds. Operations Research and Health Care. International Series in Operations Research & Management Science. Boston, MA: Springer International Publishing; 2005;70:593\u2013612","DOI":"10.1007\/1-4020-8066-2_23"},{"key":"4124_CR11","doi-asserted-by":"crossref","unstructured":"Mattila R, Siika A, Roy J, Wahlberg B. A Markov decision process model to guide treatment of abdominal aortic aneurysms. 2016 IEEE Conference on Control Applications (CCA), Buenos Aires, 2016;436\u2013441","DOI":"10.1109\/CCA.2016.7587869"},{"key":"4124_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1177\/0272989X09353194","volume":"30","author":"O Alagoz","year":"2009","unstructured":"Alagoz O, Hsu H, Schaefer AJ, Roberts MS. Markov decision processes: a tool for sequential decision making under uncertainty. Med Decis Making. 2009;30:474\u201383.","journal-title":"Med Decis Making"},{"key":"4124_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.7861\/clinmedicine.15-4-344","volume":"15","author":"HC Diener","year":"2015","unstructured":"Diener HC, Solbach K, Holle D, Gaul C. Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options. Clin Med. 2015;15:344\u201350.","journal-title":"Clin Med"},{"key":"4124_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/head.13375","volume":"58","author":"E Loder","year":"2018","unstructured":"Loder E, Rizzoli P. Pharmacologic prevention of migraine: a narrative review of the state of the art in 2018. Headache. 2018;58:218\u201329.","journal-title":"Headache"},{"key":"4124_CR15","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/head.13653","volume":"59","author":"JF Rothrock","year":"2019","unstructured":"Rothrock JF, Adams AM, Lipton RB, Silberstein SD, Jo E, Zhao X, Blumenfeld AM. FORWARD study: evaluating the comparative effectiveness of onabotulinumtoxina and topiramate for headache prevention in adults with chronic migraine. Headache. 2019;59:1700\u201313.","journal-title":"Headache"},{"issue":"1S","key":"4124_CR16","first-page":"262","volume":"39","author":"P Barbanti","year":"2019","unstructured":"Barbanti P, Aurilia C, Egeo G, Fofi L, Vernieri F. Erenumab in migraine: the first Italian real-life data. Cephalalgia. 2019;39(1S):262\u20133.","journal-title":"Cephalalgia"},{"key":"4124_CR17","unstructured":"Amgen Inc. \"Erenumab\" Package Insert. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/761077s003lbl.pdf. Accessed\u00a014 March 2025."},{"key":"4124_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/19488300.2011.619157","volume":"1","author":"BT Denton","year":"2011","unstructured":"Denton BT, Alagoz O, Holder A, Lee EV. Medical Decision Making:open research challenges. IIE Trans Healthcare Syst Eng. 2011;1:161\u20137.","journal-title":"IIE Trans Healthcare Syst Eng"},{"key":"4124_CR19","first-page":"59","volume":"29","author":"S Tunc","year":"2014","unstructured":"Tunc S, Alagoz O, Burnside E. Opportunities for Operations Research in Medical Decision Making. IEEE Intell Syst. 2014;29:59\u201362.","journal-title":"IEEE Intell Syst"},{"key":"4124_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/2381468316674214","author":"GJ Schell","year":"2016","unstructured":"Schell GJ, Marrero WJ, Lavieri MS, Sussman JB, Hayward RA. Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning. Med Decision Making Policy and Pract. 2016. https:\/\/doi.org\/10.1177\/2381468316674214.","journal-title":"Med Decision Making Policy and Pract"},{"issue":"1S","key":"4124_CR21","first-page":"211","volume":"39","author":"SJ Tepper","year":"2019","unstructured":"Tepper SJ, Lucas S, Ashina M, Schwedt TJ, Ailani J, Scanlon JV, Klatt J, Chou DE, Richards S, Lima GPS. Temporal Response Patterns to Erenumab in Patients with Chronic Migraine. Cephalalgia. 2019;39(1S):211.","journal-title":"Cephalalgia"},{"key":"4124_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s10194-018-0951-2","volume":"19","author":"S F\u00f6rderreuther","year":"2018","unstructured":"F\u00f6rderreuther S, Zhang Q, Stauffer VL, Aurora SK, Lainez MJA. Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebocontrolled EVOLVE-1, EVOLVE-2, and REGAIN studies. J Headache Pain. 2018;19:121.","journal-title":"J Headache Pain"},{"key":"4124_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/biomet\/66.3.561","volume":"66","author":"JC Gittins","year":"1979","unstructured":"Gittins JC, Jones DM. A dynamic allocation index for the discounted multiarmed bandit problem. Biometrika. 1979;66:561\u20135.","journal-title":"Biometrika"},{"issue":"10","key":"4124_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1136\/jnnp-2023-333295","volume":"95","author":"E Caronna","year":"2024","unstructured":"Caronna E, Gallardo VJ, Egeo G, V\u00e1zquez MM, Castellanos CN, Membrilla JA, Vaghi G, Rodr\u00edguez-Montolio J, Fabregat Fabra N, S\u00e1nchez-Caballero F, Jaimes S\u00e1nchez A, Mu\u00f1oz-Vendrell A, Oliveira R, G\u00e1rate G, Gonz\u00e1lez-Osorio Y, Guisado-Alonso D, Ornello R, Thunstedt C, Fern\u00e1ndez-L\u00e1zaro I, Torres-Ferr\u00fas M, Alpuente A, Torelli P, Aurilia C, P\u00e9re RL, Castrillo MJR, Icco R, Sances G, Broadhurst S, Ong HC, Garc\u00eda AG, Campoy S, Sanahuja J, Cabral G, Beltr\u00e1n Blasco I, Waliszewska-Pros\u00f3\u0142 M, Pereira L, Layos-Romero A, Luzeiro I, Dorado L, \u00c1lvarez Escudero MR, May A, L\u00f3pez-Bravo A, Martins IP, Sundal C, Irimia P, Lozano Ros A, Gago-Veiga AB, Juanes FV, Ruscheweyh R, Sacco S, Cuadrado-Godia E, Garc\u00eda-Azor\u00edn D, Pascual J, Gil-Gouveia R, Huerta-Villanueva M, Rodriguez-Vico J, Viguera Romero J, Obach V, Santos-Lasaosa S, Ghadiri-Sani M, Tassorelli C, D\u00edaz-de-Ter\u00e1n J, D\u00edaz Insa S, Oria CG, Barbanti P, Pozo-Rosich P. EUREkA study group. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world. J Neurol Neurosurg Psychiatry. 2024;95(10):927\u201337. https:\/\/doi.org\/10.1136\/jnnp-2023-333295. PMID: 38777579.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"4124_CR25","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/head.14806","volume":"64","author":"CC Chiang","year":"2024","unstructured":"Chiang CC, Schwedt TJ, Dumkrieger G, Wang L, Chao CJ, Ouellette HA, Banerjee I, Chen YC, Jones BM, Burke KM, Wang H, Murray AM, Montenegro MM, Stern JI, Whealy M, Kissoon N, Cutrer FM. Advancing toward precision migraine treatment: predicting responses to preventive medications with machine learning models based on patient and migraine features. Headache. 2024;64(9):1094\u2013108. https:\/\/doi.org\/10.1111\/head.14806. Epub 2024 Aug 23 PMID: 39176658.","journal-title":"Headache"},{"issue":"12","key":"4124_CR26","doi-asserted-by":"publisher","first-page":"333102424126275","DOI":"10.1177\/03331024241262751","volume":"44","author":"M Romozzi","year":"2024","unstructured":"Romozzi M, Lokhandwala A, Vollono C, Vigani G, Burgalassi A, Garc\u00eda-Azor\u00edn D, Calabresi P, Chiarugi A, Geppetti P, Iannone LF. An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine. Cephalalgia. 2024;44(12):3331024241262751. https:\/\/doi.org\/10.1177\/03331024241262751. PMID: 39654467.","journal-title":"Cephalalgia"},{"issue":"9","key":"4124_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/14740338.2023.2247963","volume":"22","author":"W Wells-Gatnik","year":"2023","unstructured":"Wells-Gatnik W, Martelletti P. Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal. Expert Opin Drug Saf. 2023;22(9):777\u201381. https:\/\/doi.org\/10.1080\/14740338.2023.2247963. Epub 2023 Aug 16. PMID: 37575009.","journal-title":"Expert Opin Drug Saf."},{"key":"4124_CR28","doi-asserted-by":"publisher","unstructured":"Charles AC, Digre KB, Goadsby PJ, Robbins MS, Hershey A; American Headache Society. Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: an American Headache Society position statement update. Headache. 2024;64(4):333\u2013341. https:\/\/doi.org\/10.1111\/head.14692. Epub 2024 Mar 11. PMID: 38466028.","DOI":"10.1111\/head.14692"},{"issue":"1","key":"4124_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s10194-023-01671-5","volume":"24","author":"B Raffaelli","year":"2023","unstructured":"Raffaelli B, Garc\u00eda-Azor\u00edn D, Boucherie DM, Amin FM, Deligianni CI, Gil-Gouveia R, Kirsh S, Lampl C, Sacco S, Uluduz D, Versijpt J, MaassenVanDenBrink A, Zeraatkar D, Sanchez-Del-Rio M, Reuter U. European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate. J Headache Pain. 2023;24(1):134. https:\/\/doi.org\/10.1186\/s10194-023-01671-5. PMID:37814223;PMCID:PMC10563338.","journal-title":"J Headache Pain"},{"issue":"1","key":"4124_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-023-01594-1","volume":"24","author":"C Lampl","year":"2023","unstructured":"Lampl C, MaassenVanDenBrink A, Deligianni CI, Gil-Gouveia R, Jassal T, Sanchez-Del-Rio M, Reuter U, Uluduz D, Versijpt J, Zeraatkar D, Sacco S. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. J Headache Pain. 2023;24(1):56. https:\/\/doi.org\/10.1186\/s10194-023-01594-1. PMID:37208596;PMCID:PMC10197489.","journal-title":"J Headache Pain"},{"issue":"11\u201312","key":"4124_CR31","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1177\/03331024211018137","volume":"41","author":"F Frank","year":"2021","unstructured":"Frank F, Ulmer H, Sidoroff V, Broessner G. CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: a systematic review and meta-analysis. Cephalalgia. 2021;41(11\u201312):1222\u201339. https:\/\/doi.org\/10.1177\/03331024211018137. Epub 2021 Jun 15. PMID: 34130525; PMCID: PMC8506070.","journal-title":"Cephalalgia."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04124-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T15:27:56Z","timestamp":1743434876000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04124-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4124"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04124-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.29.22273147","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IL has no financial conflict of interest. PZ: He has received honorarium from Alder Biopharmaceuticals, Board Vitals, and Fieve Clinical Research. He collaborates with Headache Science Incorporated without receiving financial support. He had ownership interest in Cymbeline LLC. He works as a consultant for Acumen LLC.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}